Ling Xiao

493 total citations
37 papers, 254 citations indexed

About

Ling Xiao is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Ling Xiao has authored 37 papers receiving a total of 254 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Pulmonary and Respiratory Medicine and 6 papers in Oncology. Recurrent topics in Ling Xiao's work include Radiomics and Machine Learning in Medical Imaging (6 papers), Prostate Cancer Diagnosis and Treatment (5 papers) and Prostate Cancer Treatment and Research (5 papers). Ling Xiao is often cited by papers focused on Radiomics and Machine Learning in Medical Imaging (6 papers), Prostate Cancer Diagnosis and Treatment (5 papers) and Prostate Cancer Treatment and Research (5 papers). Ling Xiao collaborates with scholars based in China, United States and Switzerland. Ling Xiao's co-authors include Ying Ye, Hong Zhang, Mengyao Sun, Khalid Rahman, Mengyao Sun, Yongxiang Tang, Huirong Zhang, Miaomiao Guo, Shuo Hu and Mingzhi Ye and has published in prestigious journals such as Nature Medicine, Analytical Chemistry and Scientific Reports.

In The Last Decade

Ling Xiao

32 papers receiving 248 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ling Xiao China 9 55 36 32 32 28 37 254
JI Zhao-ning China 11 126 2.3× 24 0.7× 43 1.3× 7 0.2× 24 0.9× 14 367
Jutta Haunschild Germany 12 108 2.0× 47 1.3× 46 1.4× 54 1.7× 50 1.8× 27 414
Mohammad Amin Khazeei Tabari Iran 12 131 2.4× 38 1.1× 21 0.7× 14 0.4× 20 0.7× 48 370
Seyed Hamid Madani Iran 11 58 1.1× 39 1.1× 12 0.4× 20 0.6× 41 1.5× 34 345
Ahmad E. Mostafa Egypt 12 148 2.7× 25 0.7× 63 2.0× 62 1.9× 56 2.0× 28 565
Kavita Munjal India 10 70 1.3× 22 0.6× 39 1.2× 20 0.6× 23 0.8× 42 369
Xin‐Tao Li China 10 90 1.6× 19 0.5× 21 0.7× 5 0.2× 36 1.3× 21 312
Rui Lian China 12 164 3.0× 16 0.4× 67 2.1× 42 1.3× 36 1.3× 34 434
Na Wang China 10 43 0.8× 17 0.5× 14 0.4× 13 0.4× 17 0.6× 80 265
Deepti Sharma India 10 119 2.2× 14 0.4× 30 0.9× 12 0.4× 33 1.2× 65 350

Countries citing papers authored by Ling Xiao

Since Specialization
Citations

This map shows the geographic impact of Ling Xiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling Xiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling Xiao more than expected).

Fields of papers citing papers by Ling Xiao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ling Xiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling Xiao. The network helps show where Ling Xiao may publish in the future.

Co-authorship network of co-authors of Ling Xiao

This figure shows the co-authorship network connecting the top 25 collaborators of Ling Xiao. A scholar is included among the top collaborators of Ling Xiao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ling Xiao. Ling Xiao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xiao, Ling, et al.. (2026). In vivo base editing gene therapy for heterozygous familial hypercholesterolemia: a phase 1 trial. Nature Medicine. 32(3). 1045–1051.
2.
Li, Yujia, Ling Xiao, Ming Zhou, et al.. (2025). Which patients with negative PSMA-PET imaging can safely avoid biopsy for prostate cancer? a novel step towards PSMA-based biopsy-free strategy. European Journal of Nuclear Medicine and Molecular Imaging. 52(6). 2051–2062. 2 indexed citations
3.
Molitoris, Jason K., Ling Xiao, Lisa M. Schumaker, et al.. (2025). Graph feature selection for enhancing radiomic stability and reproducibility across multiple institutions in head and neck cancer. Scientific Reports. 15(1). 27995–27995.
4.
Xiao, Ling, Matthew J. Ferris, Jason K. Molitoris, et al.. (2025). Identification of CT based radiomic biomarkers for progression free survival in head and neck squamous cell carcinoma. Scientific Reports. 15(1). 1279–1279. 2 indexed citations
5.
Shi, Yan‐Ni, et al.. (2025). USP10 stabilizes BAZ1A to drive tumor stemness via an epigenetic mechanism in head and neck squamous cell carcinoma. Cell Death and Disease. 16(1). 270–270. 1 indexed citations
6.
Wang, Weikang, Ling Xiao, Ruimei Feng, et al.. (2025). Prevalence of thyroid nodules and canceration risk assessment in TIRADS, and their relationships to obesity and dysglycemia. Frontiers in Oncology. 15. 1658717–1658717.
7.
Li, Yujia, Jian Li, Ling Xiao, et al.. (2024). Using a novel PSMA-PET and PSA-based model to enhance the diagnostic accuracy for clinically significant prostate cancer and avoid unnecessary biopsy in men with PI-RADS ≤ 3 MRI. European Journal of Nuclear Medicine and Molecular Imaging. 52(3). 913–924. 7 indexed citations
8.
Xiao, Ling, Gregory S. Alexander, Jason K. Molitoris, et al.. (2024). Radiomic biomarkers of locoregional recurrence: prognostic insights from oral cavity squamous cell carcinoma preoperative CT scans. Frontiers in Oncology. 14. 1380599–1380599. 6 indexed citations
9.
10.
Xiao, Ling, Ming Zhou, Yujia Li, et al.. (2024). [68Ga]Ga‑PSMA‑617 PET-based radiomics model to identify candidates for active surveillance amongst patients with GGG 1–2 prostate cancer at biopsy. Cancer Imaging. 24(1). 86–86. 2 indexed citations
11.
Xiao, Ling, Gregory S. Alexander, Jason K. Molitoris, et al.. (2023). Identification of CT-based non-invasive radiomic biomarkers for overall survival prediction in oral cavity squamous cell carcinoma. Scientific Reports. 13(1). 21774–21774. 13 indexed citations
12.
Liu, Junchen, Wenrui Ma, Hongyan Zhang, et al.. (2023). Anti-Inflammatory Activity of Panax notoginseng Flower Saponins Quantified Using LC/MS/MS. Molecules. 28(5). 2416–2416. 13 indexed citations
13.
Zhong, Wenhui, Huizhen Wang, Xiang Luo, et al.. (2023). Fibroblast growth factor 21 alleviates unilateral ureteral obstruction-induced renal fibrosis by inhibiting Wnt/β-catenin signaling pathway. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1871(2). 119620–119620. 5 indexed citations
14.
Hao, Min, Tianjie Li, Ling Xiao, & Yun Liu. (2023). METTL3‐induced FGD5‐AS1 contributes to the tumorigenesis and PD‐1/PD‐L1 checkpoint to enhance the resistance to paclitaxel of endometrial carcinoma. Journal of Cellular and Molecular Medicine. 28(5). e17971–e17971. 3 indexed citations
15.
Huang, Xiao‐Ying, Mingyang Ma, Ling Xiao, et al.. (2023). Associations between body composition profile and hypertension in different fatty liver phenotypes. Frontiers in Endocrinology. 14. 1247110–1247110. 2 indexed citations
16.
Li, Jian, Ling Xiao, Ming Zhou, et al.. (2023). 68Ga-PSMA PET/CT-based multivariate model for highly accurate and noninvasive diagnosis of clinically significant prostate cancer in the PSA gray zone. Cancer Imaging. 23(1). 81–81. 8 indexed citations
17.
He, Guoqian, Ling Xiao, Zhen Pan, et al.. (2022). Case report: A rare case of pulmonary mucormycosis caused by Lichtheimia ramosa in pediatric acute lymphoblastic leukemia and review of Lichtheimia infections in leukemia. Frontiers in Oncology. 12. 949910–949910. 9 indexed citations
18.
Liu, Zhuanzhuan, Yudi Li, Shihong Xu, et al.. (2022). Transcriptome analysis of Aedes albopictus midguts infected by dengue virus identifies a gene network module highly associated with temperature. Parasites & Vectors. 15(1). 173–173. 5 indexed citations
19.
Orr, Laurel, Simran Arora, Sen Wu, et al.. (2020). Bootleg: Chasing the Tail with Self-Supervised Named Entity Disambiguation. Conference on Innovative Data Systems Research. 2 indexed citations
20.
Sun, Mengyao, et al.. (2016). DAIDZEIN: A REVIEW OF PHARMACOLOGICAL EFFECTS. African Journal of Traditional Complementary and Alternative Medicines. 13(3). 117–132. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by JI Zhao-ning Breakdown of academic impact, for papers by Jutta Haunschild Breakdown of academic impact, for papers by Mohammad Amin Khazeei Tabari Breakdown of academic impact, for papers by Seyed Hamid Madani Breakdown of academic impact, for papers by Ahmad E. Mostafa Breakdown of academic impact, for papers by Kavita Munjal Breakdown of academic impact, for papers by Xin‐Tao Li Breakdown of academic impact, for papers by Rui Lian Breakdown of academic impact, for papers by Na Wang Breakdown of academic impact, for papers by Deepti Sharma
Rankless by CCL
2026